• SENSEX 78,009.25
    -70.71 (--0.09%)
  • BANKNIFTY 57,491.10
    -144.15 (--0.25%)
  • ICICI Pru Life
    511.95 706.50(%)
  • HDFC Bank
    729.65 1,020.35(%)
  • Apollo Hospitals
    8,925.00 9,326.80(%)
  • Wework India
    700.00 419.60(%)
  • LG Electronics
    1,736.35 1,736.40(%)
  • Gland Pharma
    3,039.00 3,039.00(%)
  • Bharti Airtel
    2,005.65 2,174.70(%)
  • Leap India
    143.10 143.10(%)
  • Blue Star
    1,497.00 1,450.00(%)
  • Cupid
    288.00 32.76(%)
  • Netweb Technol.
    4,995.00 2,037.65(%)
  • Honasa Consumer
    509.90 509.90(%)
  • Manorama Indust.
    1,867.00 1,867.00(%)
  • Vodafone Idea
    14.17 15.35(%)
  • Technocraft Ven.
    334.60 334.60(%)
  • Bharat Dynamics
    1,420.00 1,655.25(%)
  • Dixon Technolog.
    14,210.00 18,471.50(%)
  • Billionbrains
    194.60 112.02(%)
  • Infosys
    1,159.00 984.00(%)
  • Gujarat Fluoroch
    4,897.00 4,959.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Glaxosmithkline Pharmaceuticals Ltd Pharmaceuticals - Multinational

  • MNC Asc-Glaxo
  • BSE Code : 195.0
  • ISIN : INE159A01016
2,688.80 21 (0.79%)
  • As on 14 Aug 2026 (EOD)

  • Today’s Low

    2,648.00

  • Today’s High

    2,697.00

  • Open

    2,667.00

  • Perv Close

    2,667.70

  • 52W Low

    2,088.10

  • 52W High

    2,883.40

Key Indicators

  • P/E(TTM)

    43.04

  • Mar.Cap (₹Cr.)

    45,549.89

  • Div & Yield %

    2.12

  • Book Value(₹)

    132.30

  • Debt-Equity Ratio

    0.79

  • AGM Date

    14-Aug-2026

  • EPS

    62.48

  • P/E Ratio

    43.04

Financials Ratios

  • Debt-Equity Ratio

    0.01

  • Mar.Cap (₹Cr.)

    45,549.89

  • RONW (%)

    37.32

  • ROCE (%)

    44.97

Score Board

  • Equity (₹ in Cr.)

    169.41

  • BV (₹)

    132.30

  • Sales( ₹ in Cr.)

    3,790.20

  • NP (in Cr.)

    907.82

  • NP Var(%)

    10.0

  • Div%

    570.0

  • CPS (₹)

    57.50

  • EPS (₹)

    53.60

  • Traded Value (₹ in Lakhs)

    45,140.78

  • 52 Week High

    2,883.40

  • 52 Week Low

    2,088.10

  • Price BSE

    2665.0

  • Price NSE

    2,668.00

  • Market Capital( in Cr.)

    45,140.78

  • P/C Ratio

    46.30

  • P/E Ratio

    49.70

  • Price Vs.BV

    53.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 3,790.20 3,723.49 3,407.25 3,216.34 3,217.51 2,920.48
Other Income 145.20 147.26 143.17 114.96 1,423.27 217.71
Stock Adjustments -13.50 -51.23 69.64 -67.25 -13.83 26.12
Total Income 3,921.90 3,819.52 3,620.06 3,264.05 4,626.95 3,164.31
EXPENDITURE :            
Raw Materials 1,310.52 1,315.97 1,358.07 1,182.78 1,281.91 1,275.49
Power and Fuel Cost 30.36 30.18 29.64 29.60 27.83 26.08
Employee Cost 607.25 579.70 624.39 594.99 610.23 616.16
Other Manufacturing Expenses 101.49 114.26 113.61 99.05 120.14 110.59
Selling and Administration Expenses 366.21 383.95 374.71 370.30 343.57 242.00
Miscellaneous Expenses 60.68 78.91 239.12 84.32 85.69 287.75
Employee Benefit Expenses 607.25 579.70 624.39 594.99 610.23 616.16
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,476.51 2,502.98 2,739.54 2,361.04 2,469.38 2,558.07
Operating Profit 1,445.40 1,316.54 880.52 903.01 2,157.57 606.24
Interest 2.73 1.31 1.80 1.81 1.99 3.53
Gross Profit 1,442.67 1,315.23 878.72 901.20 2,155.58 602.71
Depreciation 66.44 66.79 69.68 65.77 68.19 78.60
Profit Before Tax 1,376.23 1,248.44 809.04 835.43 2,087.39 524.11
Current Tax 354.95 323.18 235.71 246.05 407.36 158.67
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 9.46 6.20 -11.36 -18.37 -10.49 7.87
Reported Net Profit 1,011.82 919.05 584.69 607.75 1,690.53 357.57
Extraordinary Items 104.00 92.04 -66.58 21.05 11.18 -117.79
Adjusted Net Profit 907.82 827.01 651.27 586.70 1,679.35 475.36
Adjustment below Net Profit 0.00 0.00 0.00 -17.08 -11.05 0.00
P & L Balance brought forward 1,044.37 870.71 828.12 1,745.02 562.71 882.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 711.51 745.39 542.10 1,524.66 508.22 677.62
P & L Balance carried down 1,344.68 1,044.37 870.71 811.03 1,733.98 562.71
Dividend 0.00 203.29 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 570.00 540.00 320.00 320.00 900.00 300.00
Dividend Per Share(Rs) 57.00 54.00 32.00 32.00 90.00 30.00
Earnings Per Share-Unit Curr 59.73 54.25 34.51 35.88 99.79 21.11
Earnings Per Share(Adj)-Unit Curr 59.73 54.25 34.51 35.88 99.79 21.11
Book Value 132.30 115.06 105.31 103.48 158.06 88.37
Book Value(Adj)-Unit Curr 132.30 115.06 105.31 103.48 158.06 88.37

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 127,054,524 75.00 127,054,524 4
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 127,054,524 75.00 127,054,524 4
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 94 0.00 94 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 18,086 0.01 11,084 19
Foreign Bank 1,811 0.00 1,811 2
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 8,107,430 4.79 8,107,430 242
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 4,689,441 2.77 4,689,441 16
Mutual Funds / UTI 8,245,074 4.87 8,231,954 36
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 262,315 0.15 249,431 18
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 21,324,251 12.59 21,291,245 335
2] Non Institution
Bodies Corporate 1,316,774 0.78 1,304,678 950
Clearing Members 353 0.00 353 3
Directors of their Relatives 600 0.00 600 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 881,657 0.52 874,813 4,175
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 423,852 0.25 423,852 2,435
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 371,374 0.22 371,374 12
Individuals holding nominal share capital up to Rs. 1 lakh 16,932,867 10.00 15,854,080 118,143
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 39,537 0.02 39,537 28
Others 1,060,245 0.63 1,060,245 1
Sub Total 21,027,259 12.41 19,929,532 125,748
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 169,406,034 100.00 168,275,301 126,087

Company Background

Glaxosmithkline Pharmaceuticals LtdPharmaceuticals - Multinational

  • Glaxosmithkline Pharmaceuticals Ltd
  • BSE Code : 195.0
  • ISIN : INE159A01016

  • Incorporation Year

    1924

  • Registered Office

    GSK House
    Dr Annie Besant Road Worli, Mumbai,
    Maharashtra-400030

  • Telephone

    91-022-24959595

  • FAX

    91-022-24959494

  • Chairman

    Renu S. Karnad

  • Managing Director

    Bhushan Akshikar

  • Company Secretary

    A A Nadkarni

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Glaxosmithkline Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Glaxosmi. Pharma 2,689.10 3,932.76 3,790.20 42.96 58.17
Abbott India 27,076.90 7,217.19 6,929.05 35.63 43.78
Astrazeneca Phar 7,753.70 2,304.07 2,275.58 114.28 27.86
Sanofi India 3,246.40 1,857.10 1,837.40 23.09 54.17
Novartis India 1,586.70 398.23 356.27 40.07 16.64
Cipla 1,450.00 20,102.60 18,979.95 38.11 13.88
Bliss GVS Pharma 524.05 773.53 729.81 48.66 12.51
Amrutanjan Healt 494.75 469.50 451.82 26.50 21.89
Fermenta Biotec. 449.40 474.15 450.25 20.98 18.77
Guj. Themis Bio. 349.05 152.47 150.80 78.09 27.21
Ambalal Sarabhai 42.47 19.52 3.94 78.65 6.77